Anna–Liisa Levonen

11.1k total citations · 3 hit papers
99 papers, 8.8k citations indexed

About

Anna–Liisa Levonen is a scholar working on Molecular Biology, Biochemistry and Physiology. According to data from OpenAlex, Anna–Liisa Levonen has authored 99 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 23 papers in Biochemistry and 17 papers in Physiology. Recurrent topics in Anna–Liisa Levonen's work include Genomics, phytochemicals, and oxidative stress (38 papers), Eicosanoids and Hypertension Pharmacology (14 papers) and Nitric Oxide and Endothelin Effects (12 papers). Anna–Liisa Levonen is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (38 papers), Eicosanoids and Hypertension Pharmacology (14 papers) and Nitric Oxide and Endothelin Effects (12 papers). Anna–Liisa Levonen collaborates with scholars based in Finland, United States and Japan. Anna–Liisa Levonen's co-authors include Emilia Kansanen, Hanna Leinonen, Suvi Linna-Kuosmanen, Victor Darley‐Usmar, Seppo Ylä‐Herttuala, Henna-Kaisa Jyrkkänen, Dale A. Dickinson, Anup Ramachandran, Albena T. Dinkova‐Kostova and Otis C. Attucks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Anna–Liisa Levonen

96 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

2013 1.1k citations Emilia Kansanen, Suvi Linna-Kuosmanen et al. profile →
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

2019 1.0k citations Antonio Cuadrado, Ana I. Rojo et al. Nature Reviews Drug Discovery profile →
The KEAP1-NRF2 pathway: Targets for therapy and role in cancer

2023 168 citations Ashik Jawahar Deen, Emilia Kansanen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna–Liisa Levonen Finland	44	5.7k	1.2k	986	891	881	99	8.8k
Yasutake Katoh Japan	24	10.8k 1.9×	848 0.7×	745 0.8×	1.1k 1.2×	782 0.9×	32	12.9k
Hyun‐Ock Pae South Korea	51	4.5k 0.8×	957 0.8×	806 0.8×	956 1.1×	542 0.6×	146	8.0k
Junichi Fujii Japan	53	6.1k 1.1×	1.5k 1.2×	821 0.8×	806 0.9×	647 0.7×	265	11.8k
Tak Yee Aw United States	48	4.4k 0.8×	1.4k 1.2×	1.9k 1.9×	834 0.9×	685 0.8×	138	10.5k
Ramaroson Andriantsitohaina France	57	4.7k 0.8×	2.1k 1.8×	664 0.7×	1.1k 1.3×	1.2k 1.3×	250	10.4k
Rajesh K. Thimmulappa United States	39	6.2k 1.1×	939 0.8×	403 0.4×	1.3k 1.5×	761 0.9×	81	9.1k
Qiang Ma United States	46	5.4k 1.0×	765 0.6×	352 0.4×	1.1k 1.2×	1.1k 1.3×	111	10.2k
Gérard Lizard France	53	4.4k 0.8×	957 0.8×	497 0.5×	1.6k 1.8×	531 0.6×	248	8.8k
Joohun Ha South Korea	58	6.2k 1.1×	1.6k 1.3×	491 0.5×	765 0.9×	1.3k 1.5×	173	10.4k
Michael A. Trush United States	48	4.8k 0.9×	1.2k 0.9×	483 0.5×	898 1.0×	1.1k 1.2×	121	9.6k

Countries citing papers authored by Anna–Liisa Levonen

Since Specialization

Citations

This map shows the geographic impact of Anna–Liisa Levonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna–Liisa Levonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna–Liisa Levonen more than expected).

Fields of papers citing papers by Anna–Liisa Levonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna–Liisa Levonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna–Liisa Levonen. The network helps show where Anna–Liisa Levonen may publish in the future.

Co-authorship network of co-authors of Anna–Liisa Levonen

This figure shows the co-authorship network connecting the top 25 collaborators of Anna–Liisa Levonen. A scholar is included among the top collaborators of Anna–Liisa Levonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna–Liisa Levonen. Anna–Liisa Levonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levonen, Anna–Liisa, et al.. (2022). Global MicroRNA Profiling of Vascular Endothelial Cells. Methods in molecular biology. 2475. 157–186.

Sakhteman, Amirhossein, et al.. (2021). A toxicogenomic data space for system-level understanding and prediction of EDC-induced toxicity. Environment International. 156. 106751–106751. 13 indexed citations

Linna-Kuosmanen, Suvi, Maria Bouvy‐Liivrand, Henri Niskanen, et al.. (2020). NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli. Cardiovascular Research. 117(5). 1339–1357. 44 indexed citations

Cuadrado, Antonio, Ana I. Rojo, Geoffrey Wells, et al.. (2019). Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery. 18(4). 295–317. 1034 indexed citations breakdown →

Pölönen, Petri, Ashik Jawahar Deen, Hanna Leinonen, et al.. (2019). Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma. Oncogene. 38(50). 7473–7490. 66 indexed citations

Jauhiainen, Suvi, Johanna P. Laakkonen, Kirsi Ketola, et al.. (2019). Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function. Frontiers in Physiology. 10. 224–224. 19 indexed citations

Liddell, Jeffrey R., Šárka Lehtonen, Clare Duncan, et al.. (2016). Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes. Journal of Neuroinflammation. 13(1). 49–49. 42 indexed citations

Levonen, Anna–Liisa. (2014). Activation of stress signaling pathways by oxidized and nitrated lipids. Free Radical Biology and Medicine. 75. S8–S8. 5 indexed citations

Leinonen, Hanna, et al.. (2014). Role of the Keap1–Nrf2 Pathway in Cancer. Advances in cancer research. 122. 281–320. 135 indexed citations

10.

Savinainen, Juha R., Emilia Kansanen, Tatu Pantsar, et al.. (2014). Robust Hydrolysis of Prostaglandin Glycerol Esters by Human Monoacylglycerol Lipase (MAGL). Molecular Pharmacology. 86(5). 522–535. 35 indexed citations

11.

Pomeshchik, Yuriy, Ekaterina Savchenko, Taisia Rõlova, et al.. (2013). Does Nrf2 Gene Transfer Facilitate Recovery After Contusion Spinal Cord Injury?. Antioxidants and Redox Signaling. 20(8). 1313–1323. 18 indexed citations

12.

Leinonen, Hanna, Anna‐Kaisa Ruotsalainen, Ann‐Marie Määttä, et al.. (2012). Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment. Cancer Research. 72(23). 6227–6235. 37 indexed citations

13.

Kansanen, Emilia, Henna-Kaisa Jyrkkänen, & Anna–Liisa Levonen. (2011). Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids. Free Radical Biology and Medicine. 52(6). 973–982. 177 indexed citations

14.

Bochkov, Valery N., Olga Oskolkova, Konstantin G. Birukov, et al.. (2009). Generation and Biological Activities of Oxidized Phospholipids. Antioxidants and Redox Signaling. 12(8). 1009–1059. 465 indexed citations

15.

Kansanen, Emilia, Henna-Kaisa Jyrkkänen, Oscar L. Volger, et al.. (2009). Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells. Journal of Biological Chemistry. 284(48). 33233–33241. 141 indexed citations

16.

Tuomisto, Tiina T., Emilia Kansanen, Sanna-Kaisa Häkkinen, et al.. (2008). Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovascular Research. 78(1). 175–184. 99 indexed citations

17.

Kanninen, Katja M., Tarja Malm, Henna-Kaisa Jyrkkänen, et al.. (2008). Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Molecular and Cellular Neuroscience. 39(3). 302–313. 206 indexed citations

18.

Bräsen, Jan Hinrich, Olli Leppänen, Matias Inkala, et al.. (2007). Extracellular Superoxide Dismutase Accelerates Endothelial Recovery and Inhibits In-Stent Restenosis in Stented Atherosclerotic Watanabe Heritable Hyperlipidemic Rabbit Aorta. Journal of the American College of Cardiology. 50(23). 2249–2253. 41 indexed citations

19.

Brookes, Paul S., Anna–Liisa Levonen, Sruti Shiva, Paolo Sarti, & Victor Darley‐Usmar. (2002). Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radical Biology and Medicine. 33(6). 755–764. 243 indexed citations

20.

Levonen, Anna–Liisa, Risto Lapatto, Mika Saksela, & Kari O. Raivio. (2000). Expression of γ-Glutamylcysteine Synthetase During Development. Pediatric Research. 47(2). 266–266. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact